%
Medication Adherence Score
Meet Arthur
DayaMed’s Arthur platform seeks to improve lives of consumers from the moment they receive a prescription. An intelligent platform ensures medication adherence and refill delivery. Real-time information with instant communication tools provides caregivers peace of mind and providers an ability to engage with family members efficiently.
The innovative disruptive technology of Arthur has established a new metric for patient-centered disease management – “Real-time Medication Adherence (RMA)”. An auditable metric that conveys the place, time, and the exact medication taken by the patient.
In a recent Internal Review Board (IRB) approved study with two major universities, DayaMed’s solution has been shown to improve medication adherence of patients by 280% above the national average.
The pharmacy amber vial and medication possession ratio metric are tools and data points of a by-gone era.
.
My Rewards Points
Easy to Use
Patients confirm medication adherence using an existing medication vial, multi-unit dose pouch, or other container using DayaMed’s proprietary visual intelligence and wireless solution. Patients receive a customized dose-specific experience upon confirmation of adherence.
Personalized
Patients use a wearable, phone and/or tablet to receive customized smart notification reminders. The platform requires no user programming as the patient’s protocol is retrieved from the Pharmacy Information System. Patients can also receive reminders to take their biometric readings.
Engaging
Patients, caregivers and health providers receive customized text, in-app and web portal alerts of medication adherence or biometric readings. The patient’s approved medical ecosystem participants are enabled to communicate directly with the platform using their app, online portal, or through a simple phone call.
Real-time Pharmacy Logistics
DayaMed partnership with FedEx provides same-day delivery and reverse logistics. This partnership offers exisiting pharmacy customers an exclusive platform for same-day delivery of medications and consumer products with real-time tracking. By combining the power of FedEx healthcare logistics with DayaMed’s solution, patients, hospitals and payor organizations are able to achieve the IHI Triple Aim of improved clinical outcomes, reduced healthcare costs, and an enhanced patient and provider experience.
medPOD® | Powered by Arthur
The medPOD, powered by Arthur, dispenses multi-unit dose packs of medication. The device has a large curved, AMOLED Edge-to-Edge display creating an immersive and easy to navigate experience for the patient. The display features always-on-technology allowing the patient to quickly glance at their current schedule or update from their caregivers.
A glowing LED and speaker on the sides provide visual and audible adherence and communication notifications. The patient’s specific therapeutic directions and information on medication, disease state, and caregivers comes customized and pre-loaded for the patient.
The patient is able to communicate with their caregivers, providers, and pharmacists in real-time using video conferencing. The select members of the care team and family receive real-time notifications from the medPOD. The patient has complete control over their data privacy, and communication access. All patient information is treated within strict HIPAA guidelines.
Value
Many factors can keep patients from taking their medicines – from vaguely written prescriptions and pharmacy inaccuracies to patient forgetfulness, confusion, and even physical & mental challenges. Our innovative technology platform is a patient-centered, customized communication hub that revolutionizes the way patients experience the pharmacy process and interaction with their medication regimen and caregivers. Arthur is designed especially for patients with chronic or acute conditions, and for organizations deploying value-based population health solutions.
Arthur’s platform is powered by machine learning, artificial intelligence, big data analytics, augemented reality and near field communication to empower and ensure medication adherence and secure communication while raising clinical therapeutic outcomes and managing healthcare premiums.
Hospitals
In 2018, hospital readmissions due to the patient’s relapse cost the government more than $300 billion. Under new health reform laws hospitals now bear the staggering cost of these relapse readmissions, and may be penalized for quality metrics.
The primary cause for hospital readmissions is identified as a breakdown in continuity of care. Upon discharge from the hospital, the sudden change of setting and lack of a single entity to oversee a patient’s compliance with their therapeutic regimen can lead to confusion, human error, as well as the impact of negative social factors. This leads to lower compliance that can increase risk of relapse and expense to the hospital.
Arthur's capacity to ensure continuity of care and real-time disease management translates to lower hospital readmission rates due to relapse. This equates to a higher quality of care and lower hospital related costs. Additionally, Arthur provides real-time analytics to the hospital providing data as to whether the re-admission was due to non-adherence or poor patient care.
Arthur's real-time dose-specific feature enhances compliance and eliminates the potential for confusion and mental challenges. Arthur also acts as a biometric hub, able to relay blood pressure, glucose, weight, pulse ox, EKG, and activity data directly to the hospital EHR, or customized hospital portal or app. And, with the DayaMed cloud database tracking the patient’s compliance and biometrics, physicians can utilize an event-based system to efficiently respond promptly to patient needs.
As pay-for-outcome models become more attractive for physicians, low compliance not only means poor therapeutic outcome but also reduced profit. Poor communication and an inability to respond promptly when patient compliance falters or continuity of care is not maintained are challenges for physicians striving to provide quality care.
And for at-risk physician groups who are financially responsible for poor therapeutic outcomes the challenge is even greater. Poor therapeutic outcomes mean increased expenditures.
Insurance
Providers
75% of the healthy insured population, support 5% of the insured members who are most chronically ill. These chronic illnesses, primarily diabetes, high cholesterol, and high blood pressure are preventable and treatable. However, when patient compliance goes down, disease incidents increase, inflating insurance premiums even for those without illness.
Arthur's ability to improve a patient’s compliance of their therapeutic regimen as well as inform insurance companies about the patient’s compliance status not only improves that patient’s health, but lowers healthcare costs for everyone. Insurance companies now have the ability to base incentives on a patient’s compliance with their treatment regimen while implementing a value-based insurance design.
Payors are able to provide to patients a real-time content management system for delivery of interactive wellness programs through the communication and content management platform.
The data collected by Arthur empowers predictive modeling for payors enabling ROI by rapidly targeting resources on patient populations that require the most help, which in the end reduces the cost for all.
Pharmaceutical
Companies
With insurance companies evaluating medicine and treatments based on comparative effectiveness, pharmaceutical companies are concerned with accurate assessments of their products’ efficacy. Low compliance rates negatively affect these assessments and may prompt insurance carriers to add a competitive company’s medication to their formulary.
By increasing patient compliance rates, Arthur leads to improved and more accurate assessments of a medication’s efficacy. This information is vital to pharmaceutical manufacturers who can now use real-time clinical metrics to demonstrate their product’s comparative effectiveness.
Arthur also provides a communication and content management platform for pharmaceutical companies that can be customized to specific disease states and medication to further elevate therapeutic outcomes. The platform includes a customized online portal and app.
Government
Governments across the globe are the worlds biggest payors. Single payor systems and Medicare/Medicaid are constantly seeking new tools and services to deploy for their population health programs. Arthur achieves the triple aim by improving the patient experience, lowering costs, and raising clinical outcomes.
Regulatory and consumer protection agencies have programs in place to monitor the safety of drugs available to the public either over the counter or by prescription. By accessing payor database records, these agencies can see which medicines where prescribed and in what doses.However, they lack the ability to track patient compliance, crucial information for constructing an accurate real-time data metric of the potential threat of tainted or non-effective medications. Arthur's critically focused advantage of real-time compliance and prescription drug usage data metric enables governmental regulatory agencies to promptly manage these issues during crises situations.
Traditionally households were known to extend beyond the nuclear family. However, contemporary family structures are now far more relationally and geographically spread out. With grown children living in other states and even other countries, the lack of available family support also contributes to low medication and disease management adherence rates. Even with family members who live in the same town, busy daily schedules and responsibilities prevent caregivers and family members from accompanying the patient to every appointment or supervising their treatment regimen.
Regardless of distance, family members can provide support for loved ones using Arthur. Accessing their loved one’s records via the caregiver app or portal, family members can review compliance status. They can also receive texts, emails, or phone and video calls about non-adherence within the prescribed treatment regimen. If needed they make a call to their family member to check in. Support from family members can improve compliance rates, which leads to improved therapeutic outcomes.
Identity theft is a critical concern, particularly among the elderly. Once a social security number is stolen, it can be used to obtain medicine the cost of which is then charged to Medicare. Without the ability to track the medication, this $60 billion dollar a year crime will continue. Arthur's ability to track drug regimens translates to patient peace-of-mind against identity theft and defense against costly Medicare fraud.
Employers
Employers are constantly striving for new programs to engage their employees and retirees in wellness programs to keep them motivated, healthy, and fit. Arthur enables employers and their 3rd party administrators to engage their healthy and chronically ill population. Arthur provides a custom wellness content management system and portal for the employer, and 3rd party administrator to engage the population with custom health and wellness initiatives from diabetes management, to staying active, and even providing a portal to access nutritious diet information.
Employers and their 3rd party administrators are able to collect medication adherence and biometric data to keep their population healthy while using these data points to incentivize their patients with reduced premiums or other non-financial incentives. These real-time patient generated data points are key elements to the gamification of healthcare programs.
Pharmacies
Arthur or the medPOD® is provided directly to the patient from the pharmacy. DayaMed certifies 3rd party pharmacies to dispense the medPOD® and refill cartridges. The medPOD® can be dispensed from a retail, specialty, or mail-order pharmacy.
Pharmacies are able to target and enhance their Medication Therapy Management for patients using Arthur or the medPOD®. Pharmacists are able to video conference with the patient using their app or customized online portal. Patients can reach out for help to their pharmacists when they require it, dose specifically.
Additionally, pharmacies are able to track in real-time the inventory of medication left in the medPOD®. This allows for automatic fillings of prescriptions, better management of the patient’s disease state, and elevated therapeutic outcomes.
Hospitals
In 2014, hospital readmissions due to the patient’s relapse cost the government more than $289 billion. Under new health reform laws hospitals now bear the staggering cost of these relapse readmissions, and may be penalized for quality metrics.
The primary cause for hospital readmissions is identified as a breakdown in continuity of care. Upon discharge from the hospital, the sudden change of setting and lack of a single entity to oversee a patient’s compliance with their therapeutic regimen can lead to confusion, human error, as well as the impact of negative social factors. This leads to lower compliance that can increase risk of relapse and expense to the hospital.
The medPOD’s capacity to ensure continuity of care and real-time disease management translates to lower hospital readmission rates due to relapse. This equates to a higher quality of care and lower hospital related costs. Additionally, the medPOD provides real-time analytics to the hospital providing data as to whether the re-admission was due to non-adherence or poor patient care.
The medPOD dispenses pre-sorted prescribed medication pouches customized to each patient’s drug regimen, this real-time dose-specific medPOD feature enhances compliance and eliminates the potential for confusion and mental challenges. The medPOD also acts as a biometric hub, able to relay blood pressure, glucose, weight, pulse ox, EKG, and Samsung Gear S2 activity data directly to the hospital EHR, or customized hospital medPOD portal or app. And, with the DayaMed cloud database tracking the patient’s compliance and biometrics, physicians can utilize an event-based system to efficiently respond promptly to patient needs.
As pay-for-outcome models become more attractive for physicians, low compliance not only means poor therapeutic outcome but also reduced profit. Poor communication and an inability to respond promptly when patient compliance falters or continuity of care is not maintained are challenges for physicians striving to provide quality care.
And for at-risk physician groups who are financially responsible for poor therapeutic outcomes the challenge is even greater. Poor therapeutic outcomes mean increased expenditures.
Insurance
75% of the healthy insured population, support 5% of the insured members who are most chronically ill. These chronic illnesses, primarily diabetes, high cholesterol, and high blood pressure are preventable and treatable. However, when patient compliance goes down, disease incidents increase, inflating insurance premiums even for those without illness.
The MedPod’s ability to improve a patient’s compliance of their therapeutic regimen as well as inform insurance companies about the patient’s compliance status not only improves that patient’s health, but lowers healthcare costs for everyone. Insurance companies now have the ability to base incentives on a patient’s compliance with their treatment regimen while implementing a value-based insurance design.
Payors are able to provide to patients a medPOD powered real-time content management system for delivery of interactive wellness programs through the medPOD’s communication and content management platform.
The data collected by the medPOD hub empowers predictive modeling for payors enabling ROI by rapidly targeting resources on patient populations that require the most help, which in the end reduces the cost for all.
Pharmaceutical Companies
With insurance companies evaluating medicine and treatments based on comparative effectiveness, pharmaceutical companies are concerned with accurate assessments of their products’ efficacy. Low compliance rates negatively affect these assessments and may prompt insurance carriers to add a competitive company’s medication to their formulary.
By increasing patient compliance rates, the medPOD leads to improved and more accurate assessments of a medication’s efficacy. This information is vital to pharmaceutical manufacturers who can now use real-time clinical metrics to demonstrate their product’s comparative effectiveness.
The medPOD also provides a communication and content management platform for pharmaceutical companies that can be customized to specific disease states and medication to further elevate therapeutic outcomes. The platform includes a customized medPOD online portal and app.
Government
Governments across the globe are the worlds biggest payors. Single payor systems and Medicare/Medicaid are constantly seeking new tools and services to deploy for their population health programs. The medPOD achieves the triple aim by improving the patient experience, lowering costs, and raising clinical outcomes.
Regulatory and consumer protection agencies have programs in place to monitor the safety of drugs available to the public either over the counter or by prescription. By accessing payor database records, these agencies can see which medicines where prescribed and in what doses.However, they lack the ability to track patient compliance, crucial information for constructing an accurate real-time data metric of the potential threat of tainted or non-effective medications. The medPOD’s critically focused advantage of real-time compliance and prescription drug usage data metric enables governmental regulatory agencies to promptly manage these issues during crises situations.
Traditionally households were known to extend beyond the nuclear family. However, contemporary family structures are now far more relationally and geographically spread out. With grown children living in other states and even other countries, the lack of available family support also contributes to low medication and disease management adherence rates. Even with family members who live in the same town, busy daily schedules and responsibilities prevent caregivers and family members from accompanying the patient to every appointment or supervising their treatment regimen.
Regardless of distance, family members can provide support for loved ones using the medPOD. Accessing their loved one’s records via the medPOD portal, family members can review compliance status. They can also receive texts, emails, or phone and video calls about non-adherence within the prescribed treatment regimen. If needed they make a call to their family member to check in. Support from family members can improve compliance rates, which leads to improved therapeutic outcomes.
Identity theft is a critical concern, particularly among the elderly. Once a social security number is stolen, it can be used to obtain medicine the cost of which is then charged to Medicare. Without the ability to track the medication, this $60 billion dollar a year crime will continue. The medPOD’s ability to track drug regimens translates to patient peace-of-mind against identity theft and defense against costly Medicare fraud.
Employers
Employers are constantly striving for new programs to engage their employees and retirees in wellness programs to keep them motivated, healthy, and fit. The medPOD enables employers and their 3rd party administrators to engage their healthy and chronically ill population. The medPOD provides a custom wellness content management system and portal for the employer, and 3rd party administrator to engage the population with custom health and wellness initiatives from diabetes management, to staying active, and even providing a portal to access nutritious diet information.
Employers and their 3rd party administrators are able to collect medication adherence and biometric data to keep their population healthy while using these data points to incentivize their patients with reduced premiums or other non-financial incentives. These real-time patient generated data points are key elements to the gamification of healthcare programs.
Pharmacies
The medPOD is provided directly to the patient from the pharmacy. DayaMed certifies 3rd party pharmacies to dispense the medPOD and refill cartridges. The medPOD can be dispensed from a retail, specialty, or mail-order pharmacy.
Pharmacies are able to target and enhance their Medication Therapy Management for patients using the medPOD. Pharmacists are able to video conference with the patient on their medPOD using their app or customized online portal. Patients can reach out for help to their pharmacists when they require it, dose specifically.
Additionally, pharmacies are able to track in real-time the inventory of medication left in the medPOD. This allows for automatic fillings of prescriptions, better management of the patient’s disease state, and elevated therapeutic outcomes.
Learn More About Our Global Partners
DayaMed has partnered with global icons to empower, deploy, and support the Arthur platform across the world. Together we are changing the way population health and pharmacy is experienced one patient at a time.
Press
Here’s what people have to say about DayaMed.
Contact Us,
We'd Love to Hear from You!
Please contact us to learn more, ask a question, or just keep in touch!
Executive Team
Learn more about the DayaMed team below.
Justin Daya | CEO & Co-Founder
Justin has a medical and legal background with 15 years of startup experience in healthcare, strategic partner formation, channel strategy maturation, product and IP development, regulatory, big data, IoT and machine learning.
Tushar Singh | CTO
Tushar is an experienced CTO and entrepreneur in healthcare, education, gaming, and financial services startups. He specializes on architecture that allows for rapid scaling as well as rapid development. His expertise includes utilization of data in real-time for both analytics, AI and machine learning.
Lynn Saphire, MPH, APRN | CSO
Lynn was formerly Vice President of Health Products at United Healthcare. During her 10-year tenure at United, she led teams in chronic care management, population health and innovative research.
Mike Swanson | COO
Mike was formerly Managing Director at FedEx. He worked at FedEx for over 25 years. He helped develop FedEx’s healthcare vertical, including, the GPO, IDN and private equity group.
Dr. Kanti Daya | CMO & Co-Founder
Dr. Daya has a medical and legal background with 25 years of startup experience in healthcare, product development and regulatory.
Troy B. Parkes | CBO
Troy has been involved in startup development for over a decade. He recently created and launched the first research and technology park at the University of Memphis. His expertise extends in the image of the brand, increasing the value of the brand and building a unified culture around the brand.
Brett Holtby | VP of Operations
Brett has 25 years experience of progressive responsibilities in the healthcare and software industry. Most recently Director of Strategic Initiatives at Centric Health. Prior to that Brett successfully exited with Vector Innovations as COO.
Board of Directors & Advisors
Learn more about DayaMed’s key advisors.
Thomas Mann | Executive Chairman
Thomas is a seasoned banker and investor. Served in various senior management roles with JPMorgan Chase, AXA Equitable, and Societe Generale. Successful entrepreneur founding Constellation Financial Management. Currently serves on various mutual fund and entrepreneurial boards.
Vincent E. Kerr, MD
Vincent very recently left his position as the President of Care Solutions and Chief Health Officer for National Accounts at United Healthcare. Formerly he was Chief Medical Officer at Ford Motor Company and was Global Corporate Medical Director at GE. He serves on multiple industry group boards and is trained as both an internal and occupational physician.
Jim Gay, BSc. Pharm, RPh
Jim is a pharmacist with 30 years’ experience. His areas of practice include community, long term care, administrative, regulatory and entrepreneurial activities with an emphasis on innovative technology. Jim has served in the private industry, on government boards and in academia.